BIOCOM is a California-based trade association that represents biopharmaceutical and life sciences companies. It lobbies Congress on trade and supply chain policies, intellectual property protections (patents and copyrights), drug pricing changes such as parts of the Inflation Reduction Act, federal health and privacy rules, and tax and budget issues affecting its members. Filings show regular advocacy for stronger supply chains and against policies seen as weakening IP rights.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ms LAURE FABREGA CLARK
The latest disclosures for this client.
BIOCOM
Q2BIOCOM
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
BIOCOM
ms MEGAN ELIZABETH KASTNER
BIOCOM
BIOCOM
Q4BIOCOM
Q3BIOCOM
Q2BIOCOM
Q1BIOCOM
Q1